| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mendelian susceptibility to Immune Disorders v0.16 | ZNFX1 | Zornitza Stark Publications for gene: ZNFX1 were set to 33876776 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.15 | ZNFX1 | Chirag Patel Classified gene: ZNFX1 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.15 | ZNFX1 | Chirag Patel Gene: znfx1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.14 | ZNFX1 | Chirag Patel reviewed gene: ZNFX1: Rating: GREEN; Mode of pathogenicity: None; Publications: PubMed: 33872655, 34708404; Phenotypes: Immunodeficiency 91 and hyperinflammation, MIM# 619644; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.14 | ZNFX1 | Zornitza Stark Phenotypes for gene: ZNFX1 were changed from Susceptibility to mycobacterial infection to Immunodeficiency 91 and hyperinflammation, MIM# 619644 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.13 | ZNFX1 | Zornitza Stark edited their review of gene: ZNFX1: Changed phenotypes: Immunodeficiency 91 and hyperinflammation, MIM# 619644 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.10 | ZNFX1 | Zornitza Stark Marked gene: ZNFX1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.10 | ZNFX1 | Zornitza Stark Gene: znfx1 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.10 | ZNFX1 | Zornitza Stark Classified gene: ZNFX1 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.10 | ZNFX1 | Zornitza Stark Gene: znfx1 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.9 | ZNFX1 |
Zornitza Stark gene: ZNFX1 was added gene: ZNFX1 was added to Mendelian susceptibility to Immune Disorders. Sources: Literature Mode of inheritance for gene: ZNFX1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ZNFX1 were set to 33876776 Phenotypes for gene: ZNFX1 were set to Susceptibility to mycobacterial infection Review for gene: ZNFX1 was set to AMBER Added comment: Four indviduals from two unrelated kindreds reported with intermittent monocytosis and mycobacterial disease, including bacillus Calmette-Guérin-osis and disseminated tuberculosis. Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||